Millennials’ Newest Obsession Blamed For Locking Them Out Of Housing Market
A new trend among millennials in Australia, using GLP-1 weight-loss injections, is affecting their ability to buy homes due to reduced borrowing capacity. The average monthly expense of $610 on these injections can decrease borrowing power by $80,000 to $100,000.
Millennials in Australia are struggling to buy homes due to a new trend. The use of GLP-1 weight-loss injections, such as Oz*mpic and Wegovy, is reducing their borrowing capacity. These injections cost around $610 per month, which is a significant expense. Lenders are taking this expense into account when assessing loan applications, reducing borrowing power by $80,000 to $100,000. This trend is affecting millennials' ability to buy homes in the current market.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.